Regardless of President Trump’s ideas, drug and illness consultants appear to agree that hydroxychloroquine will not be a confirmed preventative measure for COVID-19.


The World Well being Group introduced Monday a “momentary pause” on the inclusion of an anti-malarial drug, which President Donald Trump stated he used to assist stave off coronavirus, in a worldwide examine on potential remedies for the illness. 

WHO director-general Tedros Adhanom Ghebreyesus stated in a information convention that the chief group overseeing the group’s “Solidarity” trial of experimental remedies determined Saturday to droop the use hydroxychloroquine in gentle a examine published in The Lancet that discovered a decrease survival price amongst hospitalized COVID-19 sufferers utilizing the drug. 

The trial’s steering committee will use the pause to permit the Information Security Monitoring Board to conduct a evaluate and appraisal of “all proof out there globally” to “adequately consider the potential advantages and harms from this drug,” Tedros stated. 

Hydroxychloroquine was one in every of 4 medication and drug mixtures included within the Solidarity trial, which has enrolled greater than 3,500 sufferers in 17 international locations, in accordance with Tedros. Different potential remedies, together with the experimental drug remdesivir and an HIV mixture remedy, are nonetheless being examined.

“We wish to use hydroxychloroquine whether it is protected and efficacious, if it reduces mortality, reduces the size of hospitalization, with out growing the hostile occasions,” stated Dr. Soumya Swaminathan, WHO’s chief scientist. Swaminathan stated she anticipated the Solidarity trial’s steering committee to evaluate the Information Security Monitoring Board’s findings throughout the subsequent two weeks. 

Can hydroxychloroquine forestall COVID-19?: President Donald Trump thinks maybe. There’s no data to support that.

Dr. Michael Ryan, WHO’s emergencies chief, stated the pause was “customary apply” and that if the evaluate doesn’t discover any issues, the usage of the drug within the solidarity trial would resume. 

“This has purely been finished as a precaution so as to have the ability to have that information reviewed and have the correct course of,” Ryan stated.

Hydroxychloroquine and chloroquine are authorized for treating lupus and rheumatoid arthritis and for stopping and treating malaria, however no massive rigorous exams have discovered them protected or efficient for stopping or treating COVID-19.

‘This can kill you’: People are warning others following Trump’s apparent use of hydroxychloroquine

‘I feel she’s a waste of time’: Trump dismisses Nancy Pelosi calling him ‘morbidly obese,’ hydroxychloroquine concern

The U.S. Food and Drug Administration cautioned in April that the drug has “not been proven to be protected and efficient for treating or stopping COVID-19” and that it shouldn’t be used “exterior of the hospital setting or a scientific trial resulting from danger of coronary heart rhythm issues.” 

Regardless of the shortage of proof that it labored and the FDA’s warning, Trump has repeatedly endorsed the usage of the drug, saying he had a “feeling” it was efficient and telling Individuals, “What do it’s a must to lose? Take it.”

The president informed reporters on Might 18 that he had been taking the drug as a prophylactic to forestall an infection. In an interview that aired Sunday, he stated he “just finished” his hydroxychloroquine routine. 

“And by the way in which, I am nonetheless right here. To the very best of my information, right here I’m,” Trump stated on  Sinclair Broadcast’s program “Full Measure With Sharyl Attkisson.” 

Trump has fiercely criticized the WHO’s dealing with of the coronavirus pandemic, accusing of appearing too slowly and too prepared to just accept China’s preliminary denial that there was no proof of human-to-human transmission. He has quickly frozen U.S. funding of the group and threatened to make it permanent by pulling out of the United Well being company totally. 

WHO has disputed Trump’s allegation that it ought to have sounded the alarm on the outbreak sooner. Tedros has vowed to have an unbiased evaluate of the group’s response “on the earliest acceptable second.”

Contributing: Kim Hjelmgaard and Courtney Subramanian, USA TODAY; The Related Press 


Present Thumbnails

Present Captions

Learn or Share this story: